Roberto Mignone insider trades: Teva Pharmaceutical Industries (TEVA) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Roberto reports to the SEC
and 2 more companies
Open-market buys and sales
26 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 18, 2026 | TEVA | ↓ Sell | 367,600 | $39.06 | $14.4M | Indirect | Sep 22, 2026 (4d) |
| Dec 16, 2025 | TEVA | ↓ Sell | 77,400 | $30.24 | $2.3M | Indirect | Dec 18, 2025 (2d) |
| Nov 26, 2025 | TEVA | ↓ Sell | 50,000 | $26.03 | $1.3M | Indirect | Dec 1, 2025 (5d) |
| Nov 6, 2025 | TEVA | ↓ Sell | 200,000 | $24.11 | $4.8M | Indirect | Nov 10, 2025 (4d) |
| Dec 20, 2024 | TEVA | ↓ Sell | 286,000 | $22.01 | $6.3M | Indirect | Dec 26, 2024 (6d) |
| Jun 18, 2024 | TEVA | ↓ Sell | 519,000 | $17.03 | $8.8M | Indirect | Jun 21, 2024 (3d) |
| Oct 1, 2020 | AVAN | ↑ Buy | 1,000,000 | $10.00 | $10.0M | Indirect | Oct 5, 2020 (4d) |
| May 10, 2018 | TEVA | ↑ Buy | 750,000 | $19.24 | $14.4M | Indirect | May 11, 2018 (1d) |
| Nov 11, 2016 | TROV | ↑ Buy | 322,472 | $3.08 | $993K | Indirect | Nov 15, 2016 (4d) |
| Jul 17, 2015 | TROV | ↑ Buy | 140,000 | $8.75 | $1.2M | Indirect | Jul 21, 2015 (4d) |
| Apr 2, 2015 | TROV | ↑ Buy | 300,000 | $6.90 | $2.1M | Indirect | Apr 6, 2015 (4d) |
| Feb 27, 2015 | TROV | ↑ Buy | 263,286 | $5.36 | $1.4M | Indirect | Feb 27, 2015 (0d) |
| Feb 6, 2015 | TROV | ↑ Buy | 444,444 | $4.50 | $2.0M | Indirect | Feb 10, 2015 (4d) |
| Sep 13, 2012 | RGDX | ↑ Buy | 3,000,000 | $1.10 | $3.3M | Indirect | Sep 17, 2012 (4d) |
| Oct 8, 2009 | TRMS | ↓ Sell | 2,136,858 | $3.53 | $7.6M | Indirect | Oct 13, 2009 (5d) |
| Dec 12, 2008 | ORCH | ↑ Buy | 915,110 | $0.65 | $595K | Indirect | Dec 16, 2008 (4d) |
| Apr 14, 2008 | JAZZ | ↑ Buy | 9,940 | $8.47 | $84K | Indirect | Apr 16, 2008 (2d) |
| Apr 11, 2008 | JAZZ | ↑ Buy | 10,724 | $8.45 | $91K | Indirect | Apr 15, 2008 (4d) |
| Apr 10, 2008 | JAZZ | ↑ Buy | 2,461 | $8.50 | $21K | Indirect | Apr 14, 2008 (4d) |
| Apr 8, 2008 | JAZZ | ↑ Buy | 300 | $8.48 | $3K | Indirect | Apr 10, 2008 (2d) |
| Apr 7, 2008 | JAZZ | ↑ Buy | 26,847 | $8.66 | $232K | Indirect | Apr 9, 2008 (2d) |
| Apr 4, 2008 | JAZZ | ↑ Buy | 1,500 | $8.74 | $13K | Indirect | Apr 8, 2008 (4d) |
| Apr 3, 2008 | JAZZ | ↑ Buy | 7,449 | $8.75 | $65K | Indirect | Apr 7, 2008 (4d) |
| Apr 2, 2008 | JAZZ | ↑ Buy | 40,779 | $8.74 | $356K | Indirect | Apr 4, 2008 (2d) |
| Mar 14, 2008 | JAZZ | ↑ Buy | 1 | $9.48 | $9 | Indirect | Mar 18, 2008 (4d) |
| Aug 21, 2007 | TRMS | ↑ Buy | 10,081 | $7.00 | $71K | Indirect | Aug 23, 2007 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other TEVA insiders
Open-market trades in the last 12 months
About Roberto Mignone's insider trades
Roberto Mignone is an insider at Teva Pharmaceutical Industries (TEVA). Since Aug 21, 2007, Roberto has reported 19 open-market purchases worth $37.0M and 7 sales worth $45.5M on SEC Form 4. In the last 12 months: 4 sales ($22.8M).
Their filings also include option exercises (22 filings), grants and awards (11 filings), shares returned to the company (3 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TEVA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.